Vimarsana
Biggest News Aggregation in the World

Hopp Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hopp Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hopp Biotech Today - Breaking & Trending Today

CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30% - Vimarsana News

CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%

Key Insights The considerable ownership by private equity firms in CureVac indicates that they collectively have a...

Source: yahoo.com
Immatics N.V. (NASDAQ:IMTX) is definitely on the radar of institutional investors who own 47% of the company - Vimarsana News

Immatics N.V. (NASDAQ:IMTX) is definitely on the radar of institutional investors who own 47% of the company

Key Insights Significantly high institutional ownership implies Immatics' stock price is sensitive to their trading...

Source: yahoo.com
CureVac N : Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) - Form 6-K -Today at 04:37 pm - Vimarsana News

CureVac N : Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) - Form 6-K -Today at 04:37 pm

CureVac N.V. Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income ...

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1 - Vimarsana News

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1

VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four WeeksVEVYE® is the Only Water-Free Ophthalmic Product with Convenient Twice-Daily (BID) DosingNASHVILLE, Tenn. & HEIDELBERG, Germany--(BUSINESS WIRE)...

Private equity firms among AC Immune SA's (NASDAQ:ACIU) largest stockholders and were hit after last week's 12% price drop - Vimarsana News

Private equity firms among AC Immune SA's (NASDAQ:ACIU) largest stockholders and were hit after last week's 12% price drop

Key Insights The considerable ownership by private equity firms in AC Immune indicates that they collectively have a...

Source: yahoo.com